BJDX Stock Analysis: Buy, Sell, or Hold?
BJDX - Bluejay Diagnostics, Inc. Common Stock
$1.72
-0.10 (-5.49%)
▼
5d:
-10.42%
30d:
-4.97%
90d:
-49.26%
HOLD
MODERATE Confidence
Analysis Updated: May 8, 2026 12:00 AM ET
Earnings: May 12, 2026
2d
Get Alerted When BJDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called BJDX this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: BJDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: BJDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: BJDX is currently trading at $1.72, which is considered oversold relative to its 30-day fair value range of $1.81 to $1.99.
Technical Outlook: Technically, BJDX is in a uptrend. The price is currently testing key support at $1.69. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: BJDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $256.00 (+14783.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, BJDX is in a uptrend. The price is currently testing key support at $1.69. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: BJDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $256.00 (+14783.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$1.81 -
$1.99
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
52.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 14783.7% below Wall St target ($256.00)
- CAUTION: 5-day price weakness (-10.4%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$1.81 -
$1.99
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$1.69
Resistance Level
$2.10
Current Trend
Uptrend
Technical data as of
May 8, 2026
Fundamental Context
Wall Street Target
$256.00
(+14783.7%)
Share & Embed Analysis
Last updated: May 08, 2026 8:51 PM ET
Data refreshes hourly during market hours. Next update: 9:51 PM
Data refreshes hourly during market hours. Next update: 9:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BJDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$84 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$394 | 53 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
23 analysts |
$326 | 58 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$108 | 56 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 56 HOLD |
